Literature DB >> 31805189

Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia.

Azra Borogovac1,2, James N George1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31805189      PMCID： PMC6963249          DOI： 10.1182/bloodadvances.2019000959

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  16 in total

1.  Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Authors:  Hasan Fattah; Dhiren Kumar; James N George; H Davis Massey; Anne L King; Kenneth D Friedman; Gaurav Gupta
Journal:  Transfusion       Date:  2017-09-20       Impact factor: 3.157

2.  Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura.

Authors:  Spero R Cataland; Marie A Scully; James Paskavitz; Paul Maruff; Leslie Witkoff; Ming Jin; Nicholas Uva; James C Gilbert; Haifeng M Wu
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

3.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

4.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

5.  The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

Authors:  Junmei Chen; William E Hobbs; Jennie Le; Peter J Lenting; Philip G de Groot; José A López
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

Authors:  Harshvardhan Upreti; Jamil Kasmani; Kathryn Dane; Evan M Braunstein; Michael B Streiff; Satish Shanbhag; Alison R Moliterno; C John Sperati; Rebecca F Gottesman; Robert A Brodsky; Thomas S Kickler; Shruti Chaturvedi
Journal:  Blood       Date:  2019-08-20       Impact factor: 22.113

7.  Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.

Authors:  Masanori Matsumoto; Koichi Kokame; Kenji Soejima; Masayoshi Miura; Syuhei Hayashi; Yasuhiko Fujii; Asayuki Iwai; Etsuro Ito; Yoichiro Tsuji; Mayuko Takeda-Shitaka; Mitsuo Iwadate; Hideaki Umeyama; Hideo Yagi; Hiromichi Ishizashi; Fumiaki Banno; Tomohiro Nakagaki; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

Review 8.  Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.

Authors:  J Donald Easton; Jeffrey L Saver; Gregory W Albers; Mark J Alberts; Seemant Chaturvedi; Edward Feldmann; Thomas S Hatsukami; Randall T Higashida; S Claiborne Johnston; Chelsea S Kidwell; Helmi L Lutsep; Elaine Miller; Ralph L Sacco
Journal:  Stroke       Date:  2009-05-07       Impact factor: 7.914

9.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

10.  The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.

Authors:  Hendrika A van Dorland; Magnus Mansouri Taleghani; Kazuya Sakai; Kenneth D Friedman; James N George; Ingrid Hrachovinova; Paul N Knöbl; Anne Sophie von Krogh; Reinhard Schneppenheim; Isabella Aebi-Huber; Lukas Bütikofer; Carlo R Largiadèr; Zuzana Cermakova; Koichi Kokame; Toshiyuki Miyata; Hideo Yagi; Deirdra R Terrell; Sara K Vesely; Masanori Matsumoto; Bernhard Lämmle; Yoshihiro Fujimura; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941
View more
  5 in total

1.  Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.

Authors:  Max A Brodsky; Senthil Sukumar; Sruthi Selvakumar; Lisa Yanek; Sarah Hussain; Marshall A Mazepa; Evan M Braunstein; Alison R Moliterno; Thomas S Kickler; Robert A Brodsky; Spero R Cataland; Shruti Chaturvedi
Journal:  Am J Hematol       Date:  2021-09-15       Impact factor: 10.047

2.  Hypertension in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Erika Tarasco; Johanna A Kremer Hovinga; James N George
Journal:  EJHaem       Date:  2020-06-10

3.  Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker.

Authors:  Ralph Wendt; Sven Kalbitz; Felix Otto; Tanja Falter; Joachim Beige; Heidi Rossmann; Bernhard Lämmle
Journal:  Front Med (Lausanne)       Date:  2021-02-26

Review 4.  The Genetic Basis of Strokes in Pediatric Populations and Insight into New Therapeutic Options.

Authors:  Milena Jankovic; Bojana Petrovic; Ivana Novakovic; Slavko Brankovic; Natasa Radosavljevic; Dejan Nikolic
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

5.  Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Jessica A Reese; Samiksha Gupta; James N George
Journal:  Blood Adv       Date:  2022-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.